golimumab

pharmaceutical drug

Details

Instance of: type of chemical entity
Subclass of: chemical compound
active ingredient in: Simponi
defined daily dose: 1.66
has characteristic: biopharmaceutical
has use: medication
legal status (medicine): boxed warning
LiverTox likelihood score: LiverTox toxicity likelihood category E*
medical condition treated: polyarthritis, colitis, ankylosing spondylitis, arthritis, ulcerative colitis, spondylitis
significant drug interaction: anakinra
subject has role: immunologic factor, monoclonal antibody
World Health Organisation international non-proprietary name: golimumab

Nothing in the MetaHistoryBook collection references this item yet.